How should a left‑side renal calculus measuring 9.4 mm × 6.2 mm be managed in a patient with intermittent abdominal pain, constipation, and no acute distress?

Management of 9.4mm Left-Sided Renal Calculus

For a left-sided renal calculus measuring 9.4mm × 6.2mm in a patient with intermittent abdominal pain, constipation, and no acute distress, ureteroscopy (URS) should be offered as first-line surgical treatment, with shock wave lithotripsy (SWL) as an acceptable alternative option. 1

Initial Assessment and Conservative Management Window

Since the patient is not in acute distress, a trial of conservative management with medical expulsive therapy (MET) using alpha-blockers can be attempted for up to 4-6 weeks from initial presentation 1. However, given the stone size of 9.4mm, spontaneous passage is unlikely—stones between 5-10mm have only a 47% chance of spontaneous passage 2.

Key decision point: The stone exceeds the 6mm cutoff that EAU guidelines use for observation, though it falls just below the 10mm threshold where AUA guidelines mandate intervention 1.

Surgical Treatment Recommendation

Primary Treatment Options:

Ureteroscopy (URS) is the preferred first-line treatment for this stone size and should be strongly considered given:

• Stone-free rates for proximal/mid ureteral stones of similar size: 81-86% 2
• Single procedure typically sufficient
• Lower retreatment rates compared to SWL

Shock Wave Lithotripsy (SWL) is an acceptable alternative with:

• Stone-free rates: 73-82% for proximal/mid ureter stones 2
• May require multiple sessions (average 0.52-0.62 additional procedures) 2
• Less invasive but lower efficacy for stones approaching 10mm

Treatment Algorithm:

1. If patient prefers minimally invasive approach and can tolerate potential multiple sessions: SWL is reasonable
2. If patient prioritizes single-session stone clearance: URS is superior
3. If stone location is in lower pole: URS or PCNL preferred over SWL (lower pole anatomy reduces SWL efficacy) 1

Critical Management Points

Medical Expulsive Therapy Protocol:

• Prescribe alpha-blocker (tamsulosin, alfuzosin, doxazosin) for 30 days 3
• Increases stone passage rate by 29% absolute increase 2
• Reduces pain episodes and unplanned healthcare visits 3

Mandatory Follow-up During Conservative Trial:

• Periodic imaging (ultrasound acceptable, CT if needed) to monitor stone position and hydronephrosis 2
• Maximum observation period: 4-6 weeks 1
• Immediate intervention required if: sepsis develops, uncontrolled pain, or progressive hydronephrosis

Common Pitfalls to Avoid:

Do not perform blind basket extraction without direct ureteroscopic visualization 2

Do not delay intervention beyond 6 weeks if stone has not passed—prolonged obstruction risks irreversible renal function loss 3

Do not assume constipation is unrelated—ensure adequate hydration (target >2L/day urine output) as dehydration may worsen both constipation and stone disease 4

Complications to Counsel Patient About:

URS complications:

• Ureteral injury: 3-6% 2
• Stricture: 1-2% 2
• Sepsis: 2-4% 2

SWL complications:

• Steinstrasse (stone street): 4-8% 2
• Need for secondary procedures: 37-62% for stones >10mm 2
• Sepsis: 3-5% 2

Special Considerations

If stone is in renal pelvis or upper/middle calyx (not specified in your case): Both fURS and SWL are equivalent first-line options for stones <20mm 1

If stone is in lower pole specifically: fURS or PCNL preferred over SWL due to unfavorable drainage anatomy 1

If patient has anatomic abnormalities (obesity, skeletal deformities): May require open or laparoscopic approach if endoscopic access is not feasible 2

Post-Treatment Surveillance

After successful stone clearance, imaging follow-up should continue for 2 years for radiopaque stones or 3 years for radiolucent stones to maintain 80% confidence of remaining stone-free 5. Stone analysis should be performed to guide metabolic evaluation and prevention strategies 6.